Gilead Sciences, Inc. 13D and 13G filings for Arcellx, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-28 5:06 pm Purchase | 2023-12-28 | 13G | Arcellx, Inc. ACLX | GILEAD SCIENCES INC. GILD | 6,720,803 12.900% | 3,242,542 (+93.22%) | Filing |
| 2023-02-06 4:05 pm Purchase | 2023-01-26 | 13G | Arcellx, Inc. ACLX | GILEAD SCIENCES INC. GILD | 3,478,261 7.300% | 3,478,261 (New Position) | Filing |